Patient-reported outcomes after long-term period of niraparib maintenance in platinum-sensitive recurrent ovarian cancer: a prospective, multicenter cohort study

Abstract Background Considering high frequency of recurrence and usage of poly (ADP-ribose) polymerase inhibitor (PARPi) maintenance, long-term usage of PARPi certainly has been a trend for relapsed ovarian cancer. However, the quality of life (QOL) and symptom control in these patients still remain...

Descripció completa

Dades bibliogràfiques

Autors principals:	Ming Du, Peng Peng, Dongyan Cao, Ninghai Cheng, Liangqing Yao, Yang Sun, Jundong Li, Hui Zhang, Ge Lou, Jie Tang, Danbo Wang, Yue Wang, Guonan Zhang, Yang Xiang
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2026-01-01
Col·lecció:	Journal of Ovarian Research
Matèries:	Ovarian cancer Niraparib Patient reported outcomes Recurrence
Accés en línia:	https://doi.org/10.1186/s13048-026-01980-8
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!